SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Depotech(depo)
DEPO 7.300+1.7%Aug 14 5:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: StockDoc who wrote (840)10/17/1998 1:01:00 AM
From: John McCarthy  Read Replies (1) of 887
 
Amazin' ... we are on with the ODAC for Nov 16th.

Here is what is going to happen:

(1) It will be approved. Then the FDA will approve it.

Once out there ....

(2) Doctors will use it for *ALL* Head and Neck cancers.

The simple reason being ... it keeps people alive longer ...
and peer pressure begets peer pressure ....

(3) Once doctors get their feet wet, and gauge which
of their patients can *stand* depocyt:they will start to
use it for other difficult cancers .... where MTX or MTX
and other combo's don't cut it.

(4) This whole FDA thing ... is a farce.

(5) Question:Is MTX a generic drug or is it made by
one manufacturer? <g>

(6) The original trial that Depo did with H&N *WAS* the largest
H&N trial EVER DONE - ANYWHERE up until that point in time.

And yes - that was only about 35 bodies.

Regards,
John
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News